LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 206 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 0.46 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $206,000 | -13.8% | 995 | -31.1% | 1.67% | +15.1% |
| Q1 2018 | $239,000 | +20.7% | 1,445 | 0.0% | 1.45% | +16.7% |
| Q4 2017 | $198,000 | +0.5% | 1,445 | 0.0% | 1.24% | +245.6% |
| Q3 2017 | $197,000 | +12.6% | 1,445 | 0.0% | 0.36% | +8.4% |
| Q2 2017 | $175,000 | +14.4% | 1,445 | 0.0% | 0.33% | +7.1% |
| Q1 2017 | $153,000 | +4.1% | 1,445 | 0.0% | 0.31% | -0.6% |
| Q4 2016 | $147,000 | -99.9% | 1,445 | 0.0% | 0.31% | +51.5% |
| Q3 2016 | $147,476,000 | +85641.9% | 1,445 | 0.0% | 0.21% | +46.1% |
| Q2 2016 | $172,000 | -99.9% | 1,445 | -33.9% | 0.14% | -4.7% |
| Q1 2016 | $233,991,000 | +98630.4% | 2,185 | 0.0% | 0.15% | +3.5% |
| Q4 2015 | $237,000 | +24.1% | 2,185 | -2.2% | 0.14% | +6.7% |
| Q3 2015 | $191,000 | +30.8% | 2,235 | +54.7% | 0.13% | +52.3% |
| Q2 2015 | $146,000 | – | 1,445 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $7,682 | 2.90% |
| VILLERE ST DENIS J & CO LLC | 483,347 | $32,287 | 2.52% |
| Monarch Partners Asset Management LLC | 62,327 | $4,163,444 | 1.23% |
| Chicago Capital, LLC | 319,054 | $21,312,820 | 1.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 285,634 | $19,080,351 | 1.09% |
| Stephens Investment Management Group LLC | 454,416 | $30,713,977 | 0.56% |
| Smith, Graham & Co., Investment Advisors, LP | 65,372 | $4,366,850 | 0.53% |
| WOODSTOCK CORP | 55,014 | $3,674,935 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,037,605 | 0.38% |
| ISTHMUS PARTNERS, LLC | 19,830 | $1,324,644 | 0.20% |